Kevin P. Bateman

Statistics

Publications

Citations

4.5K

H-Index

Active since

1991

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Merck Canada Inc. (Canada)

United States Military Academy

TransCanada (Canada)

Institute for Marine Biosciences

Kevin P. Bateman is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, pharmacy, and mass spectrometric analysis.

ORCID

Publications per year

1991–2025

Publications

Nanomole-scale high-throughput chemistry for the synthesis of complex molecules

A. Buitrago Santanilla, Erik L. Regalado, Tony Pereira et al. · Science · 2014 · 649 citations

Pharmacy, Chemical Engineering, Chemistry +13

Carrageenan-induced Paw Edema in Rat Elicits a Predominant Prostaglandin E2 (PGE2) Response in the Central Nervous System Associated with the Induction of Microsomal PGE2 Synthase-1

Jocelyne Guay, Kevin P. Bateman, Robert J. Gordon et al. · Journal of Biological Chemistry · 2004 · 269 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

MS E with mass defect filtering for in vitro and in vivo metabolite identification

Kevin P. Bateman, José Castro‐Perez, Mark Wrona et al. · Rapid Communications in Mass Spectrometry · 2007 · 254 citations

Life Sciences, Pharmacokinetics, Pharmacology +14

Quantitative-qualitative data acquisition using a benchtop orbitrap mass spectrometer

Kevin P. Bateman, Markus Kellmann, Helmut Muenster et al. · Journal of the American Society for Mass Spectrometry · 2009 · 194 citations

Life Sciences, Pharmacokinetics, Pharmacology +17

‘All‐in‐One’ analysis for metabolite identification using liquid chromatography/hybrid quadrupole time‐of‐flight mass spectrometry with collision energy switching

Mark Wrona, Timo Mauriala, Kevin P. Bateman et al. · Rapid Communications in Mass Spectrometry · 2005 · 174 citations

Life Sciences, Pharmaceutical Analysis, Pharmacology +17

1–5 of 77